Report No. 031 · Mon, 12 Oct 2026

Startup Scout: Manus

Pick of the day

Manus

A general-purpose AI agent that plans and executes multi-step tasks end to end inside its own sandboxed virtual computer, rather than just answering questions in a chat window.

manus.im

AI Agents · Beijing

Funding Round · $500M

35/50Scout score

Problem: 7
Traction: 8
Founders: 7
Market: 8
Novelty: 5

Why today

Today's pick is Manus, the Beijing general AI agent built by Butterfly Effect, whose parent company announced on October 8, 2026 that it had raised more than 500 million dollars, its first funding round since China's state planner forced Meta to abandon its roughly 2 billion dollar acquisition of the company back in April. Against a window that also included a 475 million dollar Series B for a neutral-atom quantum computing startup, a 150 million dollar Series B for an autoimmune-disease biotech, a 445 million dollar Series D for an enterprise cloud-hardware maker, and a 52.5 million dollar Series B for an AI order-to-cash agent, Manus stands out because of the sheer drama behind the round: a startup whose founders were reportedly barred from leaving China during a geopolitical review of its would-be acquirer, now striking out alone and seeking a valuation that would make it China's most valuable AI agent company.

Problem

Knowledge workers lose enormous time stitching together research, data analysis, writing and software tasks across dozens of disconnected tools and tabs. Enterprises and consumers increasingly want AI that does not just answer questions but actually finishes assignments, booking travel, building a spreadsheet model, deploying a webpage or compiling a competitive analysis, without a human babysitting every step. Chatbots answer well but still leave execution to the user, and most existing agent products are narrow, tied to a single app or workflow. That gap, between conversational AI and an assistant that can independently plan, act and verify multi-step work, is what general AI agents are trying to close.

Product

Manus is a general-purpose AI agent that runs tasks inside its own sandboxed virtual computer, complete with internet access and a persistent file system, rather than only generating text in a chat window. It layers planning and tool use on top of outside foundation models and fine-tuned versions of Alibaba's Qwen models, stitching together hundreds of external tools so it can research a topic, write code, build a webpage or produce a finished report and hand back the result instead of a set of instructions. The company positions it as closer to a digital employee than a chatbot, aimed at both individual power users and enterprise workflows.

Traction

Manus drew roughly two million people onto its waitlist within a week of its March 2025 launch, with invitation codes reportedly reselling for more than 14,000 dollars at the peak of the hype. That early frenzy has since turned into real revenue: industry estimates put its annualized run rate at around 100 million dollars by December 2025, climbing past 125 million dollars once usage-based revenue is included, with monthly growth holding above 20 percent since a mid-2025 product update. Mobile app revenue data from May 2026 also showed Manus pulling in several times its prior monthly totals.

Team

Manus is built by Butterfly Effect, co-founded by chief executive Xiao Hong and chief scientist Yichao 'Peak' Ji, both previously based in Singapore. In late 2025 Meta agreed to buy the company for roughly 2 billion dollars, and around 100 Manus employees moved into Meta's Singapore offices as the founders prepared to take on executive roles there. China's state planner blocked the deal in April 2026 over concerns about AI talent and research flowing to a US company, reportedly summoning Xiao and Ji to Beijing and barring them from leaving the country during the review, before Butterfly Effect said in August it would return to independent operations.

Funding

Butterfly Effect raised more than 500 million dollars in the round it announced on October 8, 2026, its first since the Meta deal collapsed, led by Boyu Capital and IDG Capital with existing backers Tencent, HSG and ZhenFund also participating. Bloomberg and the Wall Street Journal had reported weeks earlier that the company was targeting a valuation of about 4 billion dollars, roughly double the 2 billion dollars Meta had been willing to pay, though Manus has not confirmed a valuation itself. The company had previously raised 75 million dollars in a round led by Benchmark Capital that valued it at about 500 million dollars.

Competitors

Manus's closest rival is Genspark, another general agent product that reviewers consistently describe as the faster, cheaper, easier option for everyday users, while Manus is positioned as the deeper tool for technically demanding, multi-step research and build tasks. Both companies saw mobile revenue jump sharply through 2026, though Manus's user base is far larger. Manus also competes indirectly with the agent features major foundation-model labs are adding to their own chatbots, and with narrower, workflow-specific agents, but its pitch, and now its balance sheet, rest on being a general-purpose agent that can tackle almost any task rather than one vertical.

VC lens

Would YC fund it? Yes, with reservations: a two million person waitlist in a week and a run rate past 100 million dollars within 18 months of launch is exactly the growth curve investors chase, but the product is largely an orchestration layer over outside foundation models, so the real bet is on execution and distribution rather than defensible technology.

Biggest risk: Manus does not control the foundation models it runs on, which it licenses from outside providers alongside fine-tuned versions of Alibaba's Qwen, so its margins and roadmap depend on vendors who could raise prices, change terms, or ship competing agent features directly. A fast-moving field of lower-priced rivals like Genspark, plus agent tools from the major labs themselves, could commoditize the orchestration layer Manus is betting its reported 4 billion dollar valuation target on, especially while it operates under continued geopolitical scrutiny between China and the US.

Runners-up

Oratomic

475 million dollar Series B co-led by ARCH Venture Partners, Spark Capital and Khosla Ventures for the Pasadena neutral-atom quantum computing startup, which says it has now raised 775 million dollars in total just seven months after launching. (Oct 8)

Matchpoint Therapeutics

150 million dollar Series B co-led by Nextech Invest and Norwest for the Watertown, Massachusetts biotech advancing an oral T-cell modulator toward clinical trials for autoimmune disease. (Oct 7)

Oxide Computer

445 million dollar Series D led by Eclipse, with AMD's venture arm joining as a new investor, for the enterprise-owned cloud hardware maker financing the gap between taking rack-scale computer orders and delivering them. (Oct 9)

Stuut

52.5 million dollar Series B led by Insight Partners, with Andreessen Horowitz and Microsoft's M12 participating, for the AI agent startup automating order-to-cash workflows for finance teams. (Oct 7)

Archive

38 reports · click a row to open it

Date	Winner	One-liner	Runners-up
2026-10-19	Modal Labs	750 million dollar Series D led by Accel at a 15.75 billion dollar valuation, as the AI infrastructure startup says its annualized run rate crossed 1 billion dollars with usage tripling in five months, built on serverless GPU access for inference, training and agent sandboxes	OMass Therapeutics, Scanntech, North.cloud, Fortem Technologies
2026-10-18	Mueon	65 million dollar Series A led by Maverick Silicon, as the Portland semiconductor startup founded by two Intel veterans scales Cubelets, modular 3D blocks bundling compute, memory, power and cooling to cut AI data center power and density limits, already in use by AI chip startup d-Matrix	Estuary Biotherapeutics, Fission, Otter Health, HyLight
2026-10-17	Chariot Claims	10 million dollar Series A led by Silverton Partners, as the rebranded ClaimClam legal-tech platform scales automated matching of consumers to mass arbitration and class-action claims over hidden fees and hard-to-cancel subscriptions, building on more than 65,000 claims already processed toward an estimated 92 million dollars in settlements	Marklo, Siena, Rein Security, Peppermint
2026-10-16	Salience Labs	125 million dollar oversubscribed Series B led by Bullhound Capital, as the Oxford-spun-out photonics company wins new backing from AMD Ventures and Intel Capital for all-optical circuit switches meant to break the power and latency ceiling facing electronic switches as AI GPU clusters scale toward tens of thousands of chips	Navra, Type One Energy, Oratomic, Gallatin AI
2026-10-15	Soufflé Therapeutics	135 million dollar Series B led by Juvia Group, as the MIT bioengineer Robert Langer-founded biotech works to deliver RNA medicines to muscle and heart tissue, a problem that has stalled the entire siRNA drug class, backed by more than 3.5 billion dollars in big pharma partnerships before any program has reached the clinic	ICON, Pluto Security, Nous Research, Atomic Machines
2026-10-14	Vitalize	31 million dollar Series A led by Oak HC and FT, as the Y Combinator-backed startup unifying hospital staffing, scheduling, patient flow and capacity management expands after enterprise customers reported cutting manual scheduling work and premium labor spend	Gallatin AI, byteXL, Desible.ai, Credfix
2026-10-13	Universal Quantum	100 million dollar Series A co-led by DCVC and Firgun Ventures, a record raise for a UK quantum computing company, as the University of Sussex spinout races to prove its modular trapped-ion chiplet interconnect can out-scale newly public rivals Quantinuum and IonQ	Atlas Atomics, Type One Energy, Sabi, Catalyst
2026-10-12	Manus	500 million dollar funding round led by Boyu Capital and IDG Capital, the general AI agent's first raise since China blocked Meta's 2 billion dollar bid for the company and barred its founders from leaving the country, as Manus pursues a reported 4 billion dollar valuation on roughly 125 million dollars of annualized revenue	Oratomic, Matchpoint Therapeutics, Oxide Computer, Stuut
2026-10-11	Arena	200 million dollar Series B co-led by Lightspeed Venture Partners and Khosla Ventures at a 3.1 billion dollar valuation, as the company behind the Chatbot Arena leaderboard nearly doubles its valuation in ten months on roughly 100 million dollars of annualized revenue from selling AI evaluation and alignment benchmarking to labs and enterprises, while Scale AI's new Seal Showdown contests its neutral-referee position	Gallatin AI, Rein Security, Rivercell, TeddyHoldings.AI
2026-10-10	Multiply Labs	75 million dollar Series B led by Patrick Soon-Shiong's NantWorks with new investors AstraZeneca, Lingotto, Teradyne and Strange Ventures, as the decade-old biologics-manufacturing robotics company passes 100 million dollars raised on the strength of its first commercial sale, an up to 85 million dollar deal with Retro Biosciences, while competing against well-funded rivals Cellares and Ori Biotech to automate cell and gene therapy production	Zomint, Parakeet Health, OuterSignal, Efficient Computer
2026-10-09	RougeTx	58 million dollar Series A led by BioGeneration Ventures and Angelini Ventures with the European Investment Bank's Aurea facility and Kurma Partners also investing, as the Leiden University Medical Center spinout launches the first disease-modifying candidate for hereditary hemorrhagic telangiectasia, a bleeding disorder with no approved therapies, built on more than two decades of pericyte research	GMI Cloud, Varda Space Industries, doxx.net, Beyond Appliances
2026-10-08	General Medicine	120 million dollar Series B led by Andreessen Horowitz with Eli Lilly and Mercy Health joining, as the PillPack founders' online healthcare marketplace brings total funding to 152 million dollars less than three years after launch on hundreds of thousands of customers and an 80 Net Promoter Score	Noah, Nous Research, Buntar Aerospace, Monid
2026-10-07	Vinci	250 million dollar Series B at a 1.5 billion dollar valuation co-led by Advent, Temasek and Xora Innovation, as the Palo Alto physics foundation model startup jumps from a 46 million dollar seed and Series A disclosed last December to a tenfold valuation leap less than a year later, aiming its technology at chip design incumbents Cadence and Synopsys	Spiko, Hadrian, WhiteLab Genomics, Inbolt
2026-10-06	Pandektes	13.5 million euro Series A led by Munich's Alstin Capital, as the Copenhagen legal-research startup grows revenue sixfold and wins customers switching off LexisNexis, Westlaw, Beck and Karnov with an API-first legal data platform	OneByZero, Fleuret AI, Laki Power, RobCo
2026-10-05	PaleBlueDot AI	200 million dollar Series C at a 3.2 billion dollar valuation led by ComputeCore, as the Palo Alto AI compute platform nearly triples its valuation in under nine months on more than 5 billion dollars of signed customer contracts	Simple Energy, Elio Mortgage, Menos AI, SedMed
2026-10-04	Flow Engineering	50 million dollar Series B at a 750 million dollar valuation co-led by Valor Equity Partners and Atreides Management, as the AI-native systems-engineering platform for hardware teams grows to over 100 million requirements managed and adds General Motors, Anduril and Intuitive Machines as customers less than a year after its Series A	Miter, Kanu AI, Beltic, Satlyt
2026-10-03	EliseAI	350 million dollar round at a 4 billion dollar valuation led by Andreessen Horowitz and Bessemer Venture Partners, as the housing and healthcare conversational AI company nearly doubles its valuation in thirteen months on 200 million dollars of ARR and five straight years of 100 percent revenue growth	Kahua, Breye Therapeutics, Amara, Kuro
2026-10-02	Armadin	255.5 million dollar Series B co-led by Andreessen Horowitz and Accel at a 2.5 billion dollar valuation, as Mandiant founder Kevin Mandia's agentic attacker-swarm security platform runs live attack campaigns for Fortune 500 and government customers seven months after stealth	Foundational, Seeds Fincap, Numeral, Chamelio
2026-10-01	General Intuition	220 million dollar Series B at a 6.2 billion dollar valuation, nearly tripling in three months, as the AI foundation model startup trains action models on billions of gameplay clips from its own sister company Medal	Varda, Jeeves, Sand.ai, Arivihan
2026-09-30	Tiny Health	Oversubscribed $33M Series B led by B Capital as the at-home microbiome testing company posts 1,624% three-year revenue growth and quadruples its practitioner-facing business	Modulate, erad, Baselayer, Ande
2026-09-29	Instinct	$1B Series C led by Sequoia, Benchmark and Coatue at a $10B valuation, a roughly 4x jump in five weeks, as its text-message AI agent passes 100,000 users with 10% daily compounding growth	SiMa.ai, Quartermaster, Outmarket AI, Humanos
2026-09-28	Solcoa Industries	$75M seed ($45M equity led by Bain Capital Ventures plus $30M JPMorgan-anchored debt) to build a 500-tonne Nevada plant using a novel rare-earth metalmaking process, aimed at breaking China's 95% grip on metallization	Clastix, Prevision Medicine, Spiich, Barq
2026-09-27	Ultraviolette	$85M Series E led by Yali Capital and TDK Ventures; Bengaluru performance EV motorcycle maker plans US entry by 2027 on 4-5x revenue growth	Micro1, Kasvu Therapeutics, HIFI, Dextr AI
2026-09-26	Island	$400M Series F led by Evolution Equity Partners at a $6.4B valuation, more than doubling its 2024 valuation as the enterprise browser expands into governing AI agents	Cyera, Confido, Heidi Health, Firecrawl
2026-09-25	Ema	$77M Series B led by Creaegis, more than quadrupling its valuation as every existing backer doubled down and Wipro scales its AI Employees to 240,000+ workers	Ando, Kasvu Therapeutics, HIFI, Nuvah
2026-09-24	TEKEVER	$580M Series D led by UC Investments and Baillie Gifford; Ukraine-proven AI surveillance drone maker hits $6.4B valuation on a new 400M pound UK Army contract	Enveda Biosciences, Basecamp Research, Numeral, Brahma AI
2026-09-23	Verda	$189M oversubscribed Series B led by Emergence Capital; profitable Nordic GPU cloud crosses $1B valuation on $165M ARR	Snorkel AI, Nexstrom, MacroCycle, Demoverse
2026-09-22	BCI-Sonics	RMB 200M (~$30M) Pre-Series A led by HSG and Yunqi Capital; non-invasive ultrasound brain-computer interface racing China's invasive BCI leaders and OpenAI-backed Merge Labs	Spott, HighLife, CellPoint, Benford
2026-09-22	Amber Electric	€49M Series E led by Morgan Stanley's 1GT; automates 50%+ of Australia's home batteries, expanding VPP software into Europe via E.ON	Corridor, Paymob, Unit1 Studio, Drivn
2026-09-18	TypeSafe AI	$40M seed led by DCVC; "System One" model returns typed decisions for software, not chat — built by RLHF co-inventor Diogo Almeida	Space Epoch, Facilo, Treble Technologies, DheyaTech
2026-09-17	Exein	$270M Series C at $1.7B valuation (30x in 2 yrs); kernel-level security layer for robots, drones and autonomous machines	Anew Labs, Delos Data, CADDi, AIUC
2026-09-16	Euclyd	€200M+ Series A; Samsung-backed (investor + manufacturer) AI inference chip built to out-efficiency Nvidia, chaired by ex-ASML CEO	Profound, Flam, ENCOS, Nutshell Therapeutics
2026-09-15	Fortaegis	$50M oversubscribed Series A; quantum-safe security rooted in silicon, chaired by Quantinuum founder Ilyas Khan	Qupital, Tandem Health, Atomarine, UniqYou
2026-09-11	Positron AI	$875M Series C at $5B valuation; memory-first inference chips challenging Nvidia's HBM lock-in	The Boring Company, Mach Industries, Rogo Technologies, Swish
2026-09-10	Cognition AI	$2B+ Series E at $48B valuation; Devin autonomous coding agent nears $900M run-rate	DigitalPaani, Algomatic Dynamics, Limetax, Fundly.ai
2026-09-09	Bluecore Energy	Floating nuclear reactor barges for ports; $50M seed just 2 months after stealth launch	QNu Labs, ARC Ride, Circolife, Hope Care
2026-09-08	Pixxel	$100M Series C, India's largest spacetech round; building orbital AI data centers	Nua, Navana.ai, GalaxEye, Atoms (Kalanick)
2026-09-07	Medulance	GPS-dispatched ambulance network raises ₹24 Cr Series A-2	Comet, Mokobara, Kit (Speakeasy), XDOF

Sources

Compiled from search results: article pages were unreachable from the publishing environment on this date, so every fact here was cross-checked against at least two independent reports.